Androgens in Health and Disease.pdf - E Library
Androgens in Health and Disease.pdf - E Library
Androgens in Health and Disease.pdf - E Library
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Chapter 6/Mutations of the AR 119<br />
24. Ris-Stalpers C, Kuiper GG, Faber PW, et al. Aberrant splic<strong>in</strong>g of <strong>and</strong>rogen receptor mRNA results <strong>in</strong><br />
synthesis of a nonfunctional receptor prote<strong>in</strong> <strong>in</strong> a patient with <strong>and</strong>rogen <strong>in</strong>sensitivity. Proc Natl Acad<br />
Sci USA 1990;87:7866–8670.<br />
25. Ris-Stalpers C, Verleun-Mooijman MC, de Blaeij TJ, et al. Differential splic<strong>in</strong>g of human <strong>and</strong>rogen<br />
receptor pre-mRNA <strong>in</strong> X-l<strong>in</strong>ked Reifenste<strong>in</strong> syndrome, because of a deletion <strong>in</strong>volv<strong>in</strong>g a putative<br />
branch site. Am J Hum Genet 1994;54:609–617.<br />
26. McPhaul MJ, Marcelli M, Zoppi S, et al. Mutations <strong>in</strong> the lig<strong>and</strong>-b<strong>in</strong>d<strong>in</strong>g doma<strong>in</strong> of the <strong>and</strong>rogen<br />
receptor gene cluster <strong>in</strong> two regions of the gene. J Cl<strong>in</strong> Invest 1992;90:2097–2101.<br />
27. Marcelli M, Zoppi S, Wilson CM, et al. Am<strong>in</strong>o acid substitutions <strong>in</strong> the hormone-b<strong>in</strong>d<strong>in</strong>g doma<strong>in</strong> of<br />
the human <strong>and</strong>rogen receptor alter the stability of the hormone receptor complex. J Cl<strong>in</strong> Invest<br />
1994;94:1642–1650.<br />
28. Marcelli M, Tilley WD, Zoppi S, et al. Androgen resistance associated with a mutation of the <strong>and</strong>rogen<br />
receptor at am<strong>in</strong>o acid 772 (ArggCys) results from a comb<strong>in</strong>ation of decreased messenger ribonucleic<br />
acid levels <strong>and</strong> impairment of receptor function. J Cl<strong>in</strong> Endocr<strong>in</strong>ol Metab 1991;73:318–325.<br />
29. Wilson CM, Griff<strong>in</strong> JE, Wilson JD, et al. Immunoreactive <strong>and</strong>rogen receptor expression <strong>in</strong> patients<br />
with <strong>and</strong>rogen resistance. J Cl<strong>in</strong> Endocr<strong>in</strong>ol Metab 1992;75:1474–1478.<br />
30. Lubahn DB, Brown TR, Simental JA, et al. Sequence of the <strong>in</strong>tron/exon junctions of the cod<strong>in</strong>g region<br />
of the human <strong>and</strong>rogen receptor gene <strong>and</strong> identification of a po<strong>in</strong>t mutation <strong>in</strong> a family with complete<br />
<strong>and</strong>rogen <strong>in</strong>sensitivity. Proc Natl Acad Sci USA 1989;86:9534–9538.<br />
31. Brown TR, Lubahn DB, Wilson EM, et al. Functional characterization of naturally occurr<strong>in</strong>g mutant<br />
<strong>and</strong>rogen receptors from subjects with complete <strong>and</strong>rogen <strong>in</strong>sensitivity. Mol Endocr<strong>in</strong>ol<br />
1990;4:1759–1772.<br />
32. Gr<strong>in</strong>o PB, Isidro-Gutierrez RF, Griff<strong>in</strong> JE, Wilson JD. Androgen resistance associated with a qualitative<br />
abnormality of the <strong>and</strong>rogen receptor <strong>and</strong> responsive to high dose <strong>and</strong>rogen therapy. J Cl<strong>in</strong> Endo<br />
Metab 1989;68:578–584.<br />
33. McPhaul MJ, Marcelli M, Tilley WD, et al. Molecular basis of <strong>and</strong>rogen resistance <strong>in</strong> a family with<br />
a qualitative abnormality of the <strong>and</strong>rogen receptor <strong>and</strong> responsive to high-dose <strong>and</strong>rogen therapy. J<br />
Cl<strong>in</strong> Invest 1991;87:1413–1421.<br />
34. Langley E, Zhou ZX, Wilson EM. Evidence for an anti-parallel orientation of the lig<strong>and</strong>-activated<br />
human <strong>and</strong>rogen receptor dimmer. J Biol Chem 1995;270:29983–29990.<br />
35. Doesburg P, Kuil CW, Berrevoets CA, et al. Functional <strong>in</strong> vivo <strong>in</strong>teraction between the am<strong>in</strong>oterm<strong>in</strong>al,<br />
transactivation doma<strong>in</strong> <strong>and</strong> the lig<strong>and</strong> b<strong>in</strong>d<strong>in</strong>g doma<strong>in</strong> of the <strong>and</strong>rogen receptor. Biochemistry<br />
1997;36:1052–1064.<br />
36. Prior L, Bordet S, MA Trifiro, et al. Replacement of arg<strong>in</strong><strong>in</strong>e 773 by cyste<strong>in</strong>e or histid<strong>in</strong>e <strong>in</strong> the human<br />
<strong>and</strong>rogen receptor causes complete <strong>and</strong>rogen <strong>in</strong>sensitivity with different receptor phenotypes. Am J<br />
Hum Genet 1992;51:143–155.<br />
37. Beitel LK, Kazemi-Esfarjani P, Kaufman M, et al. Substitution of arg<strong>in</strong><strong>in</strong>e-839 by cyste<strong>in</strong>e or histid<strong>in</strong>e<br />
<strong>in</strong> the <strong>and</strong>rogen receptor causes different receptor phenotypes <strong>in</strong> cultured cells <strong>and</strong> coord<strong>in</strong>ate degrees<br />
of cl<strong>in</strong>ical <strong>and</strong>rogen resistance. J Cl<strong>in</strong> Invest 1994;94:546–554.<br />
38. P Kazemi-Esfarjani, Beitel LK, Trifiro M, et al. Substitution of val<strong>in</strong>e-865 by methion<strong>in</strong>e or leuc<strong>in</strong>e<br />
<strong>in</strong> the human <strong>and</strong>rogen receptor causes complete or partial <strong>and</strong>rogen <strong>in</strong>sensitivity, respectively with<br />
dist<strong>in</strong>ct <strong>and</strong>rogen receptor phenotypes. Mol Endocr<strong>in</strong>ol 1993;7:37–46.<br />
39. Ris-Stalpers C, Trifiro MA, Kuiper GG, et al. Substitution of aspartic acid-686 by histid<strong>in</strong>e or asparag<strong>in</strong>e<br />
<strong>in</strong> the human <strong>and</strong>rogen receptor leads to a functionally <strong>in</strong>active prote<strong>in</strong> with altered hormoneb<strong>in</strong>d<strong>in</strong>g<br />
characteristics. Mol Endocr<strong>in</strong>ol 1991;5:1562–1569.<br />
40. T<strong>in</strong>cello DG, Saunders PT, Hodg<strong>in</strong>s MB, et al. Correlation of cl<strong>in</strong>ical, endocr<strong>in</strong>e <strong>and</strong> molecular<br />
abnormalities with <strong>in</strong> vivo responses to high-dose testosterone <strong>in</strong> patients with partial <strong>and</strong>rogen <strong>in</strong>sensitivity<br />
syndrome. Cl<strong>in</strong> Endocr<strong>in</strong>ology 1997;46:497–506.<br />
41. Yong EL, Ng SC, Roy AC, et al. Pregnancy after hormonal correction of severe spermatogenic defect<br />
due to mutation <strong>in</strong> <strong>and</strong>rogen receptor gene Lancet 1994;344:826–827.<br />
42. Ong YC, Wong HB, Adaikan G, Yong EL. Directed pharmacological therapy of ambiguous genitalia<br />
due to an <strong>and</strong>rogen receptor gene mutation Lancet 1999;354:1444–1445.<br />
43. T<strong>in</strong>cello DG, Saunders PT, Hodg<strong>in</strong>s MB, et al. Correlation of cl<strong>in</strong>ical, endocr<strong>in</strong>e <strong>and</strong> molecular<br />
abnormalities with <strong>in</strong> vivo responses to high-dose testosterone <strong>in</strong> patients with partial <strong>and</strong>rogen <strong>in</strong>sensitivity<br />
syndrome. Cl<strong>in</strong> Endocr<strong>in</strong>ol 1997;46:497–506.<br />
44. Radmayr C, Culig Z., Hobisch A, et al. Analysis of a mutant <strong>and</strong>rogen receptor offers a treatment<br />
modality <strong>in</strong> a patient with partial <strong>and</strong>rogen <strong>in</strong>sensitivity syndrome. Eur Urol 1998;33:222–226.